HOTAIRM1 and central nervous system cancer: In addition, HOTAIRM1 knock-down resulted in significant reduction of glioma cell invasiveness by 40–50% (Fig. 2C, Supplementary Fig. 3) and colony formation capacity by 25–40% (Fig. 2D).